Disputes over mRNA-related patents are poised to persist.
Patrice P. Jean, JD, PhD
Advertisement
Articles by Patrice P. Jean, JD, PhD
Advertisement
Latest Updated Articles
IP and COVID-19Published: March 11th 2021 | Updated: January 6th 2023
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Pharmaceutical Executive Daily: FDA Approves Hernexeos
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
What Does the Rollout of Trump Rx Reveal?
5